[1]
Zafiriou, E. et al. 2025. Non-Melanoma Skin Cancer Aggravation in Polycythemia Vera: Triggered by Ruxolitinib and Silenced With an IFN/Cemiplimab. Dermatology Practical & Conceptual. 15, 1 (Jan. 2025), 4642. DOI:https://doi.org/10.5826/dpc.1501a4642.